![](/img/cover-not-exists.png)
Demographic, Payer, and Clinical Characteristics of Patients Receiving Bevacizumab (BEV) And Ranibizumab (RAN) For Treatment of Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME)
Chung, J, Radtchenko, J, Nero, D, Nabhan, C, Kish, J, Feinberg, BVolume:
21
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.04.1641
Date:
May, 2018
File:
PDF, 82 KB
english, 2018